{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:53:01Z","timestamp":1791643981747,"version":"4.3.4"},"publisher-location":"Chichester, UK","reference-count":68,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001904.pub2","type":"reference-entry","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T12:49:08Z","timestamp":1437655748000},"source":"Crossref","is-referenced-by-count":10,"title":["Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review"],"prefix":"10.1002","author":[{"given":"Sarah J","family":"Nolan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Weston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Tudur Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"issue":"7605","key":"10.1002\/14651858.CD001904.pub2-BIB1|cit1","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1136\/bmj.39022.436389.BE","article-title":"Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial","volume":"334","author":"Banu","year":"2007","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001904.pub2-BIB2|cit2","first-page":"167","article-title":"Comparison of the effects of phenobarbital versus carbamazepine as single drug therapy in partial seizure with secondary generalization in children (abstract p722)","volume":"50 Suppl 10","author":"Bidabadi","year":"2009","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD001904.pub2-BIB3|cit3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1212\/WNL.24.5.401","article-title":"Carbamazepine for epilepsy. A controlled prospective evaluation","volume":"24","author":"Cereghino","year":"1974","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001904.pub2-BIB4|cit4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1528-1157.1996.tb00516.x","article-title":"Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study","volume":"37","author":"Chen","year":"1996","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001904.pub2-BIB5|cit5","first-page":"377","article-title":"Short-term therapy with carbamazepine and phenobarbital: effects on cognitive functioning in temporal lobe epilepsy","volume":"45\/46","author":"Cossu","year":"1984","journal-title":"Bollettino Lega Italiana contro l'Epilessia"},{"issue":"3","key":"10.1002\/14651858.CD001904.pub2-BIB6|cit6","first-page":"42","article-title":"Randomised 36-month comparative study of valproic acid, phenytoin, phenobarbital and carbamazepine efficacy in patients with newly diagnosed epilepsy with partial complex seizures","volume":"38 Suppl","author":"Czapinski","year":"1997","journal-title":"Epilepsia"},{"issue":"9003","key":"10.1002\/14651858.CD001904.pub2-BIB7|cit7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(96)90074-4","article-title":"Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy","volume":"347","author":"Silva","year":"1996","journal-title":"Lancet"},{"issue":"16","key":"10.1002\/14651858.CD001904.pub2-BIB8|cit8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/0140-6736(91)91176-U","article-title":"Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group)","volume":"337","author":"Feksi","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001904.pub2-BIB9|cit9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/jnnp.58.1.44","article-title":"Phenobarbitone, phenytoin, or sodium valproate for newly diagnosed epilepsy: a randomized comparative monotherapy trial","volume":"58","author":"Heller","year":"1995","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001904.pub2-BIB10|cit10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001904.pub2-BIB11|cit11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1528-1157.1987.tb03623.x","article-title":"Carbamazepine versus phenobarbital for partial onset seizures in children","volume":"28","author":"Mitchell","year":"1987","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD001904.pub2-BIB12|cit12","first-page":"18","article-title":"Cognitive effects of anti-epileptic drugs in Nigerians with epilepsy","volume":"24","author":"Ogunrin","year":"2005","journal-title":"African Journal of Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD001904.pub2-BIB13|cit13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0920-1211(93)90048-C","article-title":"Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment","volume":"14","author":"Placencia","year":"1993","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD001904.pub2-BIB14|cit14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1192\/bjp.112.488.737","article-title":"Tegretol (carbamazepine): a controlled trial of a new anti-convulsant","volume":"112","author":"Bird","year":"1966","journal-title":"British Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD001904.pub2-BIB15|cit15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/088307389801301104","article-title":"Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital","volume":"13","author":"Castro-Gago","year":"1998","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD001904.pub2-BIB16|cit16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1212\/WNL.23.4.357","article-title":"Evaluation of carbamazepine in epileptic patients","volume":"23","author":"Cereghino","year":"1973","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD001904.pub2-BIB17|cit17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1600-0404.1980.tb01505.x","article-title":"Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man","volume":"61","author":"Hansen","year":"1980","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD001904.pub2-BIB18|cit18","first-page":"61","article-title":"Effect of anti-epileptic drugs on serum zinc and copper concentrations in epileptic patients","volume":"31","author":"Kuzuya","year":"1993","journal-title":"International Journal of Clinical Pharmacology, Therapy, & Toxicology"},{"issue":"2","key":"10.1002\/14651858.CD001904.pub2-BIB19|cit19","first-page":"133","article-title":"Carbamazepine: behavioral, anticonvulsant and EEG effects in chronically-hospitalized epileptics","volume":"29","author":"Marjerrison","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD001904.pub2-BIB20|cit20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1212\/WNL.40.3_Part_1.391","article-title":"Comparative cognitive effects of anticonvulsants","volume":"40","author":"Meador","year":"1990","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001904.pub2-BIB21|cit21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0404.1995.tb00461.x","article-title":"Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy","volume":"92","author":"Sabers","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001904.pub2-BIB22|cit22","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1111\/j.1528-1157.1987.tb05778.x","article-title":"Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone","volume":"28","author":"Smith","year":"1987","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD001904.pub2-BIB23|cit23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1528-1157.1999.tb00748.x","article-title":"The incidence of epilepsy and unprovoked seizures in multiethnic, urban health maintenance organizations","volume":"40","author":"Annegers","year":"1999","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001904.pub2-BIB24|cit24","first-page":"528","article-title":"Phenobarbital and other barbiturates: adverse effects","volume-title":"Antiepileptic Drugs","author":"Baulac","year":"2002"},{"issue":"8968","key":"10.1002\/14651858.CD001904.pub2-BIB25|cit25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the National General Practice Study of Epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001904.pub2-BIB26|cit26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD001904.pub2-BIB27|cit27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001904.pub2-BIB28|cit28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/cpt19623123","article-title":"Comparison of the effectiveness of phenobarbital, mephobarbital, primidone, dipheylhydantoin, ethotoin, metharbital, and methylphenylhydantion in motor seizures","volume":"3","author":"Gruber","year":"1962","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD001904.pub2-BIB29|cit29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota 1935 - 1984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001904.pub2-BIB30|cit30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001904.pub2-BIB31|cit31","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001904.pub2-BIB32|cit32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","article-title":"How common are the \"common\" neurologic disorders?","volume":"68","author":"Hirtz","year":"2007","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD001904.pub2-BIB33|cit33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1528-1157.1998.tb01167.x","article-title":"Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy","volume":"39","year":"1998","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD001904.pub2-BIB34|cit34","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"issue":"7048","key":"10.1002\/14651858.CD001904.pub2-BIB35|cit35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/bmj.313.7048.36","article-title":"Trials to assess equivalence: the importance of rigorous methods","volume":"313","author":"Jones","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001904.pub2-BIB36|cit36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1528-1157.1983.tb04893.x","article-title":"Natural history of epileptic seizures","volume":"24","author":"Juul-Jenson","year":"1983","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001904.pub2-BIB37|cit37","doi-asserted-by":"publisher","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001904.pub2-BIB38|cit38","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001904.pub2-BIB39|cit39","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD001904.pub2-BIB40|cit40","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/j.1528-1157.1994.tb02549.x","article-title":"Absence seizures and carbamazepine in adults","volume":"35","author":"Liporace","year":"1994","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001904.pub2-BIB41|cit41","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1111\/j.1528-1157.1995.tb05996.x","article-title":"Antiepileptic drug mechanisms of action","volume":"36","author":"MacDonald","year":"1995","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001904.pub2-BIB42|cit42","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U","article-title":"Factors predicting prognosis of epilepsy after presentation with seizures","volume":"48","author":"MacDonald","year":"2000","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD001904.pub2-BIB43|cit43","volume-title":"Idiopathic Generalised Epilepsies: Clinical, Experimental and Genetic","author":"Malfosse","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD001904.pub2-BIB44|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001030","article-title":"Carbamazepine versus valproate monotherapy for epilepsy","author":"Marson","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001904.pub2-BIB45|cit45","first-page":"163","article-title":"Is carbamazepine safe to take during pregnancy?","volume":"58","author":"Matlow","year":"2012","journal-title":"Canadian Family Physician"},{"key":"10.1002\/14651858.CD001904.pub2-BIB46|cit46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic reviews and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1002\/14651858.CD001904.pub2-BIB47|cit47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Neuropsychiatry"},{"key":"10.1002\/14651858.CD001904.pub2-BIB48|cit48","unstructured":"Murray CJL Lopez AD Global comparative assessments in the health sector World Health Organization 1994"},{"key":"10.1002\/14651858.CD001904.pub2-BIB49|cit49","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001904.pub2-BIB50|cit50","unstructured":"National Institute for Health and Care Excellence The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care London National Institute for Health and Care Excellence"},{"key":"10.1002\/14651858.CD001904.pub2-BIB51|cit51","series-title":"Consistency of outcome and statistical reporting of time-to-event data: the impact on Cochrane Reviews and meta-analyses in epilepsy. 21st Cochrane Colloquium: Better Knowledge for Better Health","first-page":"114","author":"Nolan","year":"2013"},{"issue":"8","key":"10.1002\/14651858.CD001904.pub2-BIB52|cit52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001769.pub2","article-title":"Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures","author":"Nolan","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001904.pub2-BIB53|cit53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1474-4422(05)70172-1","article-title":"Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study","volume":"4","author":"Olafsson","year":"2005","journal-title":"Lancet Neurology"},{"issue":"9095","key":"10.1002\/14651858.CD001904.pub2-BIB54|cit54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0140-6736(97)06250-8","article-title":"Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India","volume":"351","author":"Pal","year":"1998","journal-title":"Lancet"},{"issue":"24","key":"10.1002\/14651858.CD001904.pub2-BIB55|cit55","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD001904.pub2-BIB56|cit56","first-page":"756","article-title":"Frequency and voltage dependent inhibition of type hA Na\u0131 channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs","volume":"40","author":"Ragsdale","year":"1991","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD001904.pub2-BIB57|cit57","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1113\/jphysiol.1996.sp021784","article-title":"Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons","volume":"497","author":"Rho","year":"1996","journal-title":"The Journal of Physiology"},{"issue":"5","key":"10.1002\/14651858.CD001904.pub2-BIB58|cit58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/jnnp.61.5.433","article-title":"Epidemiology of the epilepsies","volume":"61","author":"Sander","year":"1996","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001904.pub2-BIB59|cit59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0013-9580.2004.455005.x","article-title":"The use of anti-epileptic drugs - principles and practice","volume":"45","author":"Sander","year":"2004","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001904.pub2-BIB60|cit60","first-page":"7","article-title":"Sodium valproate, phenytoin and carbamazepine as sole anticonvulsants","volume-title":"The place of sodium valproate in the treatment of epilepsy","author":"Shakir","year":"1980"},{"key":"10.1002\/14651858.CD001904.pub2-BIB61|cit61","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.33.11.1487","article-title":"Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children","volume":"33","author":"Shields","year":"1983","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001904.pub2-BIB62|cit62","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1056\/NEJM198510103131503","article-title":"Exacerbation of seizures in children by carbamazepine","volume":"313","author":"Snead","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001904.pub2-BIB63|cit63","unstructured":"StataCorp Stata Statistical Software: Release 11. 2009"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001904.pub2-BIB64|cit64","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1111\/j.1528-1157.1988.tb05805.x","article-title":"Children of school age: the influence of antiepileptic drugs on behavior and intellect","volume":"29","author":"Trimble","year":"1988","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD001904.pub2-BIB65|cit65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1745-6215-8-34","article-title":"Multiple treatment comparisons in epilepsy monotherapy trials","volume":"5","author":"Tudur Smith","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD001904.pub2-BIB66|cit66","volume-title":"Guidelines for the clinical management of adults with poorly controlled epilepsy","author":"Wallace","year":"1997"},{"issue":"11","key":"10.1002\/14651858.CD001904.pub2-BIB67|cit67","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1002\/sim.1303","article-title":"Aggregate data meta-analysis with time-to-event outcomes","volume":"21","author":"Williamson","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001904.pub2-BIB68|cit68","article-title":"Carbamazepine versus phenobarbitone monotherapy for epilepsy","author":"Tudur Smith","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001904.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001904.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:06:51Z","timestamp":1628543211000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001904.pub2"}},"subtitle":[],"editor":[{"given":"Sarah J","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":68,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001904.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001904.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2015,7,23]]}}}